New York State Common Retirement Fund’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.41M | Buy |
215,830
+52,671
| +32% | +$1.08M | 0.01% | 1107 |
|
|
2025
Q1 | $3.27M | Sell |
163,159
-25,942
| -14% | -$519K | ﹤0.01% | 1221 |
|
|
2024
Q4 | $5.04M | Buy |
189,101
+5,170
| +3% | +$138K | 0.01% | 1100 |
|
|
2024
Q3 | $5.25M | Sell |
183,931
-3,800
| -2% | -$108K | 0.01% | 1079 |
|
|
2024
Q2 | $4.09M | Sell |
187,731
-40,848
| -18% | -$889K | 0.01% | 1212 |
|
|
2024
Q1 | $5.06M | Sell |
228,579
-8,547
| -4% | -$189K | 0.01% | 1110 |
|
|
2023
Q4 | $5.12M | Sell |
237,126
-8,742
| -4% | -$189K | 0.01% | 1104 |
|
|
2023
Q3 | $4.15M | Buy |
245,868
+4,635
| +2% | +$78.3K | 0.01% | 1183 |
|
|
2023
Q2 | $3.31M | Buy |
241,233
+20,308
| +9% | +$279K | ﹤0.01% | 1330 |
|
|
2023
Q1 | $5.02M | Buy |
220,925
+6,447
| +3% | +$146K | 0.01% | 1162 |
|
|
2022
Q4 | $5.05M | Buy |
214,478
+9,244
| +5% | +$218K | 0.01% | 1175 |
|
|
2022
Q3 | $5.35M | Buy |
205,234
+9,435
| +5% | +$246K | 0.01% | 1126 |
|
|
2022
Q2 | $4.3M | Buy |
195,799
+46,935
| +32% | +$1.03M | 0.01% | 1267 |
|
|
2022
Q1 | $6.68M | Buy |
148,864
+20,688
| +16% | +$928K | 0.01% | 1152 |
|
|
2021
Q4 | $5.5M | Buy |
128,176
+80,837
| +171% | +$3.47M | 0.01% | 1257 |
|
|
2021
Q3 | $3.15M | Buy |
47,339
+2,199
| +5% | +$146K | ﹤0.01% | 1513 |
|
|
2021
Q2 | $3.31M | Buy |
45,140
+14,422
| +47% | +$1.06M | ﹤0.01% | 1560 |
|
|
2021
Q1 | $2.1M | Buy |
30,718
+5,700
| +23% | +$390K | ﹤0.01% | 1755 |
|
|
2020
Q4 | $1.68M | Sell |
25,018
-4,450
| -15% | -$299K | ﹤0.01% | 1776 |
|
|
2020
Q3 | $1.52M | Buy |
29,468
+9,750
| +49% | +$502K | ﹤0.01% | 1709 |
|
|
2020
Q2 | $743K | Buy |
19,718
+14,218
| +259% | +$536K | ﹤0.01% | 2024 |
|
|
2020
Q1 | $164K | Hold |
5,500
| – | – | ﹤0.01% | 2550 |
|
|
2019
Q4 | $189K | Buy |
+5,500
| New | +$189K | ﹤0.01% | 2761 |
|